• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Radiological endpoints as surrogates for survival benefit in hepatocellular carcinoma trials: All that glitters is not gold.

作者信息

Cabibbo Giuseppe, Bruix Jordi

机构信息

Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties PROMISE, University of Palermo, Palermo, Italy.

BCLC Group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain.

出版信息

J Hepatol. 2023 Jan;78(1):8-11. doi: 10.1016/j.jhep.2022.10.018. Epub 2022 Oct 30.

DOI:10.1016/j.jhep.2022.10.018
PMID:36323356
Abstract
摘要

相似文献

1
Radiological endpoints as surrogates for survival benefit in hepatocellular carcinoma trials: All that glitters is not gold.在肝细胞癌试验中作为生存获益替代指标的放射学终点：闪光的未必都是金子。
J Hepatol. 2023 Jan;78(1):8-11. doi: 10.1016/j.jhep.2022.10.018. Epub 2022 Oct 30.
2
The prognostic role of tumour progression and liver function at progression under immunotherapy for hepatocellular carcinoma.免疫治疗下肿瘤进展及进展时肝功能对肝细胞癌的预后作用
Liver Int. 2023 Mar;43(3):528-530. doi: 10.1111/liv.15513.
3
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.肝细胞癌局部区域治疗后的甲胎蛋白反应
J Clin Oncol. 2010 Feb 20;28(6):e99; author reply e100. doi: 10.1200/JCO.2009.26.7070. Epub 2010 Jan 19.
4
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.提高免疫疗法治疗肝细胞癌抗肿瘤效果的策略。
Front Immunol. 2021 Nov 26;12:783236. doi: 10.3389/fimmu.2021.783236. eCollection 2021.
5
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response.肝细胞癌的免疫治疗：炎症、纤维化和免疫反应之间的复杂界面。
J Immunother Cancer. 2019 Oct 18;7(1):267. doi: 10.1186/s40425-019-0749-z.
6
Assessment of treatment response in hepatocellular carcinoma: a review of the literature.肝癌治疗反应评估：文献综述。
Future Oncol. 2013 Jun;9(6):845-54. doi: 10.2217/fon.13.33.
7
Focus on treatment of large hepatocellular carcinoma.专注于大肝细胞癌的治疗。
Ann Surg Oncol. 2004 Dec;11(12):1035-6. doi: 10.1245/ASO.2004.10.906.
8
Imaging for better responses to immunotherapy in hepatocellular carcinoma.用于改善肝细胞癌免疫治疗反应的成像技术。
Hepatology. 2023 Jan 1;77(1):6-9. doi: 10.1002/hep.32627. Epub 2022 Jul 10.
9
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization?经动脉化疗栓塞治疗肝细胞癌时，影像学终点是否为总生存的替代结局？
Liver Int. 2021 May;41(5):1105-1116. doi: 10.1111/liv.14822. Epub 2021 Mar 1.
10
Immunotherapy in hepatocellular cancer.肝癌的免疫治疗。
Adv Cancer Res. 2021;149:295-320. doi: 10.1016/bs.acr.2020.12.002. Epub 2021 Jan 23.

引用本文的文献

1
Prediction of Pathologic Response in Unresectable Hepatocellular Carcinoma After Downstaging with Locoregional and Systemic Combination Therapy.经局部区域和全身联合治疗降期后不可切除肝细胞癌病理反应的预测
J Hepatocell Carcinoma. 2025 Jan 16;12:43-58. doi: 10.2147/JHC.S499597. eCollection 2025.
2
Efficacy and safety of ultrasound-guided radiofrequency ablation combined with transhepatic artery embolization chemotherapy for hepatocellular carcinoma: A meta-analysis.超声引导下射频消融联合经肝动脉化疗栓塞治疗肝细胞癌的疗效和安全性：一项荟萃分析。
PLoS One. 2024 Sep 6;19(9):e0305965. doi: 10.1371/journal.pone.0305965. eCollection 2024.
3
Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis.
晚期肝细胞癌一线全身治疗的疗效与耐受性平衡：一项网状Meta分析
Liver Cancer. 2023 Jul 25;13(2):169-180. doi: 10.1159/000531744. eCollection 2024 Apr.
4
Objective Response to Systemic Therapy Is a Strong Predictor of Overall Survival in Patients with Unresectable Hepatocellular Carcinoma.全身治疗的客观反应是不可切除肝细胞癌患者总生存的有力预测指标。
Liver Cancer. 2023 Nov 29;13(1):1-5. doi: 10.1159/000535516. eCollection 2024 Feb.
5
Systemic therapies in hepatocellular carcinoma: A revolution?系统治疗在肝细胞癌中的应用：一场革命？
United European Gastroenterol J. 2024 Mar;12(2):252-260. doi: 10.1002/ueg2.12510. Epub 2024 Jan 24.
6
Breakthroughs in Hepatocellular Carcinoma Therapies.肝细胞癌治疗的突破。
Clin Gastroenterol Hepatol. 2023 Jul;21(8):2135-2149. doi: 10.1016/j.cgh.2023.01.039. Epub 2023 Feb 20.
7
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints.免疫治疗时代肝细胞癌放射学反应评估的演变情况：替代终点的优势与不足
Biomedicines. 2022 Nov 6;10(11):2827. doi: 10.3390/biomedicines10112827.